Robert L. Nussbaum - 13 Mar 2023 Form 4 Insider Report for Invitae Corp

Role
Chief Medical Officer
Signature
/s/ Thomas R. Brida, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
13 Mar 2023
Net transactions value
-$3,701
Form type
4
Filing time
15 Mar 2023, 16:23:41 UTC
Previous filing
24 Aug 2022
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVTA Common Stock Sale $3,701 -2,625 -0.58% $1.41 447,907 13 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
F2 Includes an aggregate of 272,028 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.